NCT00212823View on ClinicalTrials.gov

The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

1,450

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

February 28, 2005

Conditions

Migraine

Interventions

DRUG

almotriptan malate

All Listed Sponsors

lead

Ortho-McNeil Neurologics, Inc.

INDUSTRY

NCT00212823 - The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain | Biotech Hunter | Biotech Hunter